ArticleAfrican health sciences2025
Analysis of thoracoscopic pulmonary wedge resection, thoracoscopic lobectomy and open lobectomy in patients with lung cancer.
Article in African health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A 5-Item Prediction Model Incorporating Pain With Neuropathic Characteristics at 2 Weeks for Chronic Postsurgical Pain After Video-Assisted Thoracoscopic Lung Surgery: A Prospective Cohort Study.European journal of pain (London, England) · 2026Article
- Thoracoscopic segmentectomy versus lobectomy for early-stage non-small cell lung cancer: efficacy, postoperative recovery, and prognosis.American journal of translational research · 2026Article
- Innovations and African Health Sciences: telling it beyond our environs.African health sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: To analyze the value of thoracoscopic lung wedge resection, thoracoscopic lobectomy and open lobectomy in patients with lung cancer. Methodology: Ninety-six patients with lung cancer were divided into three groups: thoracoscopic lung wedge resection (F1 group), thoracoscopic lobectomy (F2 group), and open lobectomy (F3 group). The study assessed the patients' general condition, pulmonary function, oxidative stress indicators, quality of life (EORTC QLQ-C30), and occurrence of postoperative complications, including pulmonary infections. Results: The F1 and F2 groups outperformed the F3 group in most surgical indicators, except for lymph node count. F1 group had better results than the F2 group. Pulmonary function was better in the F1 group postoperatively compared to F2 and F3 groups. F1 and F2 groups exhibited lower levels of oxidative stress indicators, while having higher levels of SOD than the F3 group. At 3 and 6 months' post-surgery, F1 group had lower EORTC QLQ-C30 scores than F2 and F3 groups. The incidence of complications, including lung infections within 6 months after surgery, was lower in F1 and F2 groups than the F3 group. Conclusion: Thoracoscopic lung wedge resection can reduce surgical trauma and oxidative stress, alleviate lung function damage and postoperative complications, and improve the level of quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.